Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02927249
Recruitment Status : Active, not recruiting
First Posted : October 7, 2016
Last Update Posted : December 9, 2020
Sponsor:
Collaborators:
National Cancer Institute (NCI)
United States Department of Defense
Bayer
Canadian Cancer Trials Group
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : April 2021
Study Completion Date : No date given